Research Topics
Genomes and Genes
| graft vs host reactionSummarySummary: An immunological attack mounted by a graft against the host because of tissue incompatibility when immunologically competent cells are transplanted to an immunologically incompetent host; the resulting clinical picture is that of GRAFT VS HOST DISEASE. Top Publications
Research Grants
| Scientific Experts
|
Detail Information
Publications
Expression of chemokines in GVHD target organs is influenced by conditioning and genetic factors and amplified by GVHRMarkus Y Mapara
Transplantation Biology Research Center, Bone Marrow Transplantation Section, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02129, USA
Biol Blood Marrow Transplant 12:623-34. 2006....
Passenger lymphocyte syndrome with severe hemolytic anemia due to an anti-Jk(a) after allogeneic PBPC transplantationA Leo
Institute for Immunology and the Department of Internal Medicine, University Clinics of Heidelberg, Heidelberg, Germany
Transfusion 40:632-6. 2000..After allogeneic peripheral blood progenitor cell (PBPC) transplantation, a patient developed a severe hemolytic transfusion reaction due to passenger lymphocyte syndrome...
Influence of T-cell depletion on chronic graft-versus-host disease: results of a multicenter randomized trial in unrelated marrow donor transplantationSteven Z Pavletic
University of Nebraska Medical Center, Omaha, USA
Blood 106:3308-13. 2005..In spite of a significant reduction of acute GVHD, TCD did not reduce the incidence of cGVHD or improve survival in patients who developed cGVHD...
Partial HLA matching and RH incompatibility resulting in graft versus host reaction and Evans syndrome after liver transplantationCelia Grosskreutz
Bone Marrow Transplantation Program, Division of Hematology Oncology, Department of Medicine, Mount Sinai Medical Center, New York, New York, USA
Am J Hematol 83:599-601. 2008..HLA typing was critical in confirming this rare diagnosis and elucidating its cause. Recipients of solid organs from donors that are partially matched in the direction of rejection may need to be closely monitored for GVHD...
In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigensAnne M Dickinson
University Department of Haematology, Royal Victoria Infirmary, University of Newcastle, Newcastle upon Tyne, UK
Nat Med 8:410-4. 2002..These results provide the first in situ dissection of GvH effects by mHag-specific CTLs and show that ubiquitously expressed mHags are the prime targets of GvH disease...
Correlation of Hsp70-1 and Hsp70-2 gene expression with the degree of graft-versus-host reaction in a rat skin explant modelPeter Novota
Department of Cellular and Molecular Immunology, University of Gottingen, Gottingen, Germany
Transplantation 85:1809-16. 2008..New molecular markers of GVHR might help to further increase the predictive value of the assay...
Haploidentical donor T cells fail to facilitate engraftment but lessen the immune response of host T cells in murine fetal transplantationJeng-Chang Chen
Fetal Treatment Center, Department of Surgery, University of California, San Francisco, CA 94143-0793, USA
Br J Haematol 126:377-84. 2004..The persistence of donor cells in the peritoneal cavity also correlated with tolerance induction...
Correlation of donor-derived keratinocytes and severity of graft-versus-host disease (GVHD) in epidermisDaisuke Niino
Department of Molecular Pathology, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
Pathol Res Pract 200:775-81. 2005..We hypothesize that donor-derived stem cells may play a role in the regeneration of damaged keratinocytes in GVHD...
Levels of anti-A/B antibodies after ABO-incompatible hematopoietic stem cell transplantationG Stussi
Laboratory for Transplantation Immunology, , Switzerland
Transplant Proc 37:1385-7. 2005..Thus, there is no evidence for stimulation of donor B lymphocytes to produce antirecipient antibodies suggesting a potential B cell tolerance...
Post-transplantation dynamics of the immune response to chronic myelogenous leukemiaRob DeConde
Stanford Medical Informatics, Department of Medicine, Stanford University, Stanford, CA 94305, USA
J Theor Biol 236:39-59. 2005..These observations lead to the hypothesis that anti-host T cells benefit from stimulation by general host blood cells, which induce them to proliferate to sufficient levels to eliminate cancer...
Chimerism studies in HLA-identical nonmyeloablative hematopoietic stem cell transplantation point to the donor CD8(+) T-cell count on day + 14 as a predictor of acute graft-versus-host diseaseSøren L Petersen
Department of Hematology, Rigshospitalet, Copenhagen, Denmark
Biol Blood Marrow Transplant 10:337-46. 2004..A donor CD8(+) T-cell count above the median on day +14 increased the risk of subsequent development of aGVHD grades II to IV (P =.003)...
Dissociation of putative graft-versus-haematopoiesis and graft-versus-myeloma effects in patients with rapidly progressive multiple myelomaThomas Luft
Department of Hematology and Rheumatology, University of Heidelberg, Poliklinik and Medizinische Klinik V, Heidelberg, Germany
Br J Haematol 123:646-53. 2003..Secondly, the graft-versus-myeloma effect that induced CR did not correlate with FDC but was associated with grade III-IV GvHD in our group of heavily pretreated patients...
Positive and negative selection of T cell repertoires during differentiation in allogeneic bone marrow chimerasKazunori Onoe
Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan
Transpl Immunol 12:79-88. 2003..In this communication, the contribution of BM chimera systems to the investigation of the world of T-ology is discussed...
Syngeneic graft-versus-host disease: a report of two cases and literature reviewT Latif
Department of Hematology and Medical Oncology, Taussig Cancer Center, Cleveland, OH 44195, USA
Bone Marrow Transplant 32:535-9. 2003..The current report reviews these cases and presents two additional cases of severe SGVHD that have occurred at our institution...
Expression patterns of vascular endothelial growth factor in human cardiac allografts: association with rejectionMarlies E J Reinders
Department of Medicine, and Department of Pediatrics Children s Hospital, Boston, Massachusetts 02115, USA
Transplantation 76:224-30. 2003..However, little is known of the expression or function of VEGF in acute and chronic allograft rejection...
[Experimental study of optimized H-2 haploidentical hematopoietic engraftment for the treatment of murine acute leukemia model]Fan-yi Meng
Department of Hematology, Nanfang Hospital, the First Military Medical University of PLA, Guangzhou 510515, China
Zhonghua Xue Ye Xue Za Zhi 24:197-9. 2003..Those mice transfused with CD(3)(+) T lymphocyte in the graft higher than 10(8) cells died from the GVHD was significantly higher. The inclusive dosage of 5 x 10(7) CD(3)(+) T lymphocyte was enough to separate the GVHD from GVL...
[Allogeneic adoptive immunotherapy]P Tiberghien
Inserm EPI 0119 Upres EA 2284, Etablissement Français du Sang Bourgogne Franche Comté, Universite de Franche Comte, 1, Boulevard Alexandre Fleming, BP 1937, 25020 cedex, Besancon, France
Transfus Clin Biol 10:170-4. 2003..Such a transplant modality is now perceived has a very efficient form of adoptive allogeneic immunotherapy unfortunately associated with significant toxicity...
Peyer's patch is the essential site in initiating murine acute and lethal graft-versus-host reactionMasako Murai
Department of Molecular Preventive Medicine, Graduate School of Medicine, The University of Tokyo, Bunkyo ku, Japan
Nat Immunol 4:154-60. 2003..Mice deficient for PPs failed to develop a-GVHD in two models of disease induction. Thus, blockade of CTL generation in PPs might offer new strategies for circumventing a-GVHD...
Differential CD52 expression by distinct myeloid dendritic cell subsets: implications for alemtuzumab activity at the level of antigen presentation in allogeneic graft-host interactions in transplantationGudrun Ratzinger
Laboratory of Cellular Immunobiology, Department of Medicine, Weill Medical College of Cornell University, New York, NY, USA
Blood 101:1422-9. 2003..Whether these results support a separation of deleterious from beneficial graft-host interactions at the level of antigen presentation, rather than solely at the level of T cells, will require further evaluation...
Differential sensitivity of T lymphocytes and hematopoietic precursor cells to photochemotherapy with 8-methoxypsoralen and ultraviolet A lightMohamed Mabed
Hematology and Medical Oncology Unit, Faculty of Medicine, Mansoura University, Mansoura, Egypt
Ann Hematol 85:17-24. 2006..Taken together, these data show that ex vivo 8-MOP plus UV-A treatment of the marrow graft cannot be used to prevent post-bone marrow transplantation alloreactivity...
Case of a patient with progressive adult T-cell leukemia/lymphoma treated successfully by reduced-intensity conditioning stem cell transplantation from an HLA-incompatible related donorHiroshi Fujiwara
Division of Hematology Immunology, Internal Medicine, Kagoshima University Hospital, Japan
Int J Hematol 82:357-61. 2005..In addition, basiliximab combined with MMF may be effective for the treatment of steroid-refractory skin GVHD without deteriorating the graft-versus-ATL effect...
Chimerism studies as an approach for the induction of tolerance to extremity allograftsKeiichi Muramatsu
Department of Orthopedic Surgery, Yamaguchi University School of Medicine, Yamaguchi, Japan
J Plast Reconstr Aesthet Surg 61:1009-15. 2008..In this review, recent experimental chimerism studies are presented for tolerance induction and we review the prospect of clinical applicability in extremity allograft...
The thymus in GVHD pathophysiologyWerner Krenger
Laboratory of Pediatric Immunology, Department of Biomedicine, University of Basel, Basel, Switzerland
Best Pract Res Clin Haematol 21:119-28. 2008..The present review focuses on recent insight into how GVHD affects thymic function and how this knowledge aides the design of new strategies to improve immune reconstitution following allogeneic HSCT...
GVHD pathophysiology: is acute different from chronic?Tomomi Toubai
Department of Internal Medicine, Division of Hematology Oncology, University of Michigan Comprehensive Cancer Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109 0942, USA
Best Pract Res Clin Haematol 21:101-17. 2008..In this chapter we briefly discuss and contrast the pathophysiologies of acute and chronic GVHD...
The allogeneic effect revisited: exogenous help for endogenous, tumor-specific T cellsHeather J Symons
Division of Cancer Immunology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA
Biol Blood Marrow Transplant 14:499-509. 2008..These events provide the cellular mechanism of the "allogeneic effect" in antitumor immunity. Cy + CD8(-) DLI may be an effective and minimally toxic strategy for awakening the host immune response to advanced cancers...
[The experience in non-relative allogenic transplantation of stem hemopoietic cells in the Clinic of Bone Marrow Transplantation at I.P. Pavlov St-Petersburg Medical Academy]L S Zubarovskaia
Ter Arkh 79:36-43. 2007..It is necessary to create a national register of non-relative donors...
Therapy of relapsed Hodgkin lymphomaAmanda F Cashen
Division of Oncology, Washington University School of Medicine, 660 S Euclid Ave, St Louis, MO 63110, USA
Blood Rev 21:233-43. 2007..New salvage regimens that incorporate gemcitabine, vinorelbine, rituximab, and/or monoclonal antibodies against CD30 are being investigated...
Graft-versus-host disease: a surge of developmentsStanley R Riddell
Fred Hutchinson Cancer Research Center and the University of Washington School of Medicine, Seattle, Washington, United States of America
PLoS Med 4:e198. 2007
Outcomes of transplantation in children with acute leukaemiaVanderson Rocha
Bone Marrow Transplant Unit and Clinical Research Laboratory on Cell Therapy and Department of Haematology, , 75010 Paris, France
Lancet 369:1906-8. 2007
Hematopoietic cell transplantation: progress and obstaclesM Devetten
University of Nebraska Medical Center, 987680 Nebraska Medical Center, Omaha, NE 68198 7680, USA
Ann Oncol 18:1450-6. 2007..Long-term complications are starting to emerge, and will gain in importance in the near future...
[Haploidentical 2- or 3-antigen-mismatched hematopoietic stem cell transplantation using in vivo Campath-1H]Yoshinobu Kanda
Rinsho Ketsueki 47:607-17. 2006
An inflammatory checkpoint regulates recruitment of graft-versus-host reactive T cells to peripheral tissuesRonjon Chakraverty
Transplantation Biology Research Center, Bone Marrow Transplantation Section, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02129, USA
J Exp Med 203:2021-31. 2006..Our studies help to explain the paradox whereby GVH-reactive T cells can mediate graft-versus-leukemia responses without inducing GVHD in established MCs...
Single-cell cloning of human, donor-derived antileukemia T-cell lines for in vitro separation of graft-versus-leukemia effect from graft-versus-host reactionDaniela Montagna
Department of Pediatrics, Laboratory of Immunology, University of Pavia, Italy
Cancer Res 66:7310-6. 2006....
Vascularized lymph node transplantation induces graft-versus-host disease in chimeric hostsCedric G Francois
Plastic Surgery Research, Department of Surgery, University of Louisville, KY, USA
Transplantation 81:1435-41. 2006..This illustrates the important role of the LN microenvironment in adaptive immune responses...
Analysis of serum granulysin in patients with hematopoietic stem-cell transplantation: its usefulness as a marker of graft-versus-host reactionMasayuki Nagasawa
Department of Pediatrics and Developmental Biology, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan
Am J Hematol 81:340-8. 2006..These results indicate that increased release of granulysin presents alloreactivity and serum granulysin is useful as a marker of GVHD in SCT...
Graft-versus-host reactions and the effectiveness of donor lymphocyte infusionsCarol Ann Huff
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University, Baltimore, MD 21231, USA
Biol Blood Marrow Transplant 12:414-21. 2006..However, with the exception of CML, most patients die of their underlying disease because of insufficient antitumor activity even with active GVHD...
Graft rejection after unrelated donor hematopoietic stem cell transplantation for thalassemia is associated with nonpermissive HLA-DPB1 disparity in host-versus-graft directionKatharina Fleischhauer
Oncoematologia Pediatrica, IRCCS Policlinico San Matteo, P le Golgi 2, 27100 Pavia, Italy
Blood 107:2984-92. 2006..82; P = .01). These data suggest that in patients with thalassemia, the incidence of graft failure after HSCT may be reduced by appropriate selection of UDs, with such selection taking into account the functional rules of immunogenetics...
Regulation of alloimmune responses (GvH reactions) in vitro by autologous donor bone marrow cell preparation used in clinical organ transplantationJames M Mathew
Department of Surgery, University of Miami School of Medicine, Florida 33136, USA
Transplantation 74:846-55. 2002..Therefore, we questioned whether an intrinsic immunoregulatory function of (subpopulations of) DBMC might play a role in this observation...
Interleukin-10 modulation of alloreactivity and graft-versus-host reactionsXiao-Nong Wang
Department of Haematology, School of Clinical and Laboratory Sciences, University of Newcastle, Newcastle upon Tyne, United Kingdom
Transplantation 74:772-8. 2002..Responder cells producing high TNF-alpha following allogeneic stimulation appeared to be less sensitive to IL-10 modulation of GvHR...
The H-2 major histocompatibility complex and the I immune response region: genetic variation, function, and organizationD C Shreffler
Adv Immunol 20:125-95. 1975
Deficiency in the thymus-dependent immunity in "lethargic" mutant miceH C Dung
Transplantation 23:39-43. 1977..Implications of these results in understanding the immunological status of lethargic mice were considered...
Non-myeloablative hematopoietic stem cell transplantationM Maris
Fred Hutchinson Cancer Research Center, Seattle, WA, United States
Transfus Clin Biol 8:231-4. 2001....
Differential roles of IL-1 and TNF-alpha on graft-versus-host disease and graft versus leukemiaG R Hill
Department of Pediatric Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA
J Clin Invest 104:459-67. 1999..These data highlight the importance of conditioning in GVHD pathophysiology, and demonstrate that TNF-alpha is critical to GVL mediated by donor T cells, whereas IL-1 is not...
A broad T-cell repertoire diversity and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem cell transplantationKimmo Talvensaari
Laboratoire d'Immunologie et d'Histocompatibilit, INSERM U.396, , , AP-HP, Paris, France
Blood 99:1458-64. 2002..These data indicate an efficient thymic regeneration pathway from CB lymphoid progenitors despite the low number of cells infused compared to bone marrow, arguing for a complete clinical immune recovery after CB transplantation...
The use of H-2 mutants as models for the study of T cell activationI F McKenzie
Immunol Rev 35:179-230. 1977
The flavonoid Kaempferol suppresses the graft-versus-host reaction by inhibiting type 1 cytokine production and CD8+ T cell engraftmentIwao Okamoto
Fujisaki Institute, Hayashibara Biochemical Laboratories, Incorporated, Japan
Clin Immunol 103:132-44. 2002..Thus, our study indicates that Kaempferol has the capacity to modulate the Th1/Th2 balance and could be useful for the treatment of cell-mediated immune diseases, such as acute GVHD...
Human leucocyte antigen-Cw-specific cytotoxic T lymphocytes generated from naive cord blood used for cord blood stem cell transplantationMakoto Yazaki
Department of Paediatrics, Nagoya City University Medical School, 1 Kawasumi, Mizuho cho, Nagoya 467 8601, Japan
Br J Haematol 117:893-8. 2002....
Separating graft-versus-tumor from graft-versus-host reactionsA B T Fassas
Myeloma and Transplantation Research Center, University of Arkansas for Medical Sciences, Little Rock 72205, USA
Leuk Lymphoma 43:725-33. 2002....
The role of hematopoietic stem cells in the treatment of ovarian cancerA Perillo
Department of Gynecology and Obstetrics, Catholic University of the Sacred Heart, Rome, Italy
Panminerva Med 44:197-204. 2002..Perspectives in the use of HSC in oncology comprise the possibility of an HSC ex vivo expansion, the use of umbilical cord blood HSC, and the development of future HSC-based gene-therapy programs...
Response of murine and normal human skin to injection of allogeneic blood-derived psoriatic immunocytes: detection of T cells expressing receptors typically present on natural killer cells, including CD94, CD158, and CD161B J Nickoloff
Department of Pathology, Cardinal Bernardin Cancer Center, Loyola University of Chicago, Maywood, Ill 60153, USA
Arch Dermatol 135:546-52. 1999....
Suppressor function of hepatic mononuclear inflammatory cells during murine chronic graft-vs-host disease. I. Macrophage-enriched cells mediate suppression in the liverC D Howell
University of Colorado School of Medicine, Denver
Cell Immunol 132:256-68. 1991..T cells contributed to the suppressor activity of both populations. However, the suppressor activity of hepatic MC was mediated largely by a macrophage-enriched population of MC while that of splenic MC was mediated largely by NS cells...
A new approach to the blocking of alloreactive T cell-mediated graft-versus-host disease by in vivo administration of anti-CXCR3 neutralizing antibodyShan He
Institute of Health Sciences and Shanghai Institute of Immunology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences and Shanghai Jiao Tong University School of Medicine, Shanghai, China
J Immunol 181:7581-92. 2008..Thus, we have established a novel and effective approach with the potential to give rise to new clinical methods for preventing and treating GVHD after allogeneic hematopoietic stem cell transplantation...
Identification of functional T cell subsets and surface antigen changes during activation as they relate to RT6H D Hunt
Department of Microbiology, University of Iowa, Iowa City
Cell Immunol 143:194-211. 1992..Following a return to a nonactivated state, the T cells reexpress RT6. The loss and reexpression of RT6 may be related to activation and/or differentiation of T cells...
Contribution of regulatory T cells and effector T cell deletion in tolerance induction by costimulation blockadeBert Verbinnen
Division of Clinical Immunology, University Hospital, Catholic University of Leuven, Leuven, Belgium
J Immunol 181:1034-42. 2008..At later time points (>30 days after splenocyte transfer), clonal deletion of host-reactive T cells was found to be a major mechanism responsible for tolerance...
The role of corticotropin-releasing hormone in blastocyst implantation and early fetal immunotoleranceS N Kalantaridou
Division of Reproductive Endocrinology, Department of Obstetrics and Gynecology, University of Ioannina, Ioannina, Greece
Horm Metab Res 39:474-7. 2007..Defective uterine CRH/CRH-R1 system during early pregnancy may be implicated in the pathophysiology of recurrent miscarriage, placenta accreta, and preeclampsia...
JTA-009, a fully human antibody against human AILIM/ICOS, ameliorates graft-vs-host reaction in SCID mice grafted with human PBMCsNobuyuki Tajima
Biological and Pharmacological Laboratories Central Pharmaceutical Research Institute, Takatsuki, Japan
Exp Hematol 36:1514-23. 2008..In the present study, the role of human AILIM/ICOS in T-cell function was investigated using a fully human monoclonal antibody specific to human AILIM/ICOS (JTA-009)...
Thrombotic complications after haematopoietic stem cell transplantation: early and late effectsDimitrios A Tsakiris
Department of Haematology, University Hospital Basel, CH 4031 Basel, Switzerland
Best Pract Res Clin Haematol 22:137-45. 2009..This chapter will discuss the incidence, possible causative associations and treatment options of early and late thrombotic events after haematopoietic stem cell transplantation...
Identification of phosphatidylinositol 4-kinase type II beta as HLA class II-restricted target in graft versus leukemia reactivityMarieke Griffioen
Departments of Hematology and Immunohematology and Blood Transfusion, Leiden University Medical Center, P O Box 9600, 2300 RC, Leiden, The Netherlands
Proc Natl Acad Sci U S A 105:3837-42. 2008..We hypothesize that LB-PI4K2B-1S-specific CD4(+) T cells contributed to the antitumor response by both directly eliminating malignant cells as effector cells and stimulating CD8(+) T cell immunity as helper cells...
Expression of allograft inflammatory factor-1 in inflammatory skin disordersChristina Orsmark
Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden
Acta Derm Venereol 87:223-7. 2007..We conclude that AIF-1 may mediate survival and pro-inflammatory properties of macrophages in skin diseases...
[Immunomodulator effects of 2 antibiotics, chloramphenicol and kitasamycin, in the chicken]A Laval
INRA, Ecole Nationale Veterinaire d Alfort, Maisons Alfort, France
Ann Rech Vet 19:259-66. 1988..A short stimulation of cellular response is shown with kitasamycin, which stimulates GVHR, whereas chloramphenicol has a negative effect...
[Native MRT diagnosis of transplantation dysfunction--the acute graft reaction]J P Kuhn
Rofo 180:669-72. 2008
Functional modifications of the CD4+ and the CD8+ subset due to maternal serumY E Vanderbeeken
Service d' Immunologie, , Brussels, Belgium
Immunopharmacol Immunotoxicol 11:397-420. 1989..Appearing quite early during the gestation (at the 5-6th week), this factor was vanishing 2 weeks after the delivery...
Mlsa generated suppressor cells. I. Suppression is mediated by double-negative (CD3+CD5+CD4-CD8-) alpha/beta T cell receptor-bearing cellsM Bruley-Rosset
Institut de la Santé et de la Recherche Medicale Unité 267, Villejuif, France
J Immunol 145:4046-52. 1990....
Immune dysfunction associated with graft-vs-host reaction in mice transplanted across minor histocompatibility barriers. II. Reversible defect in T-dependent antibody responsesS Budhecha
Department of Biological Structure, University of Washington, Seattle 98195
J Immunol 142:3740-5. 1989....
Allogeneic peripheral blood stem cell transplantation from related donors mismatched at 2 HLA loci in the host-versus-graft directionToshihiko Ando
Third Department of Internal Medicine, Yamaguchi University School of Medicine, Ube, Japan
Tohoku J Exp Med 214:159-63. 2008..Our experience suggests that PBSC transplantation with an HVG-mismatched related donor and an appropriate conditioning regimen may be a therapeutic option for patients in whom early transplantation is desirable...
Motheaten, an immunodeficient mutant of the mouse. II. Depressed immune competence and elevated serum immunoglobulinsL D Shultz
J Immunol 116:936-43. 1976..Evidence of autoimmunity was found in motheaten mice in the granular deposition of IgM and IgG in kidney glomeruli. Motheaten mice, thus, appear to have a severe immune deficiency, but the basic nature of the deficiency is not yet known...
Suppression of cellular immunity by cord blood-derived unrestricted somatic stem cells is cytokine-dependentMeike Winter
Institute for Transplantation Diagnostics and Cell Therapeutics, Heinrich Heine University Medical Center, Dusseldorf, Germany
J Cell Mol Med 13:2465-75. 2009..Therapeutically, they may help to protect USSC and possibly their progeny from immune rejection...
ABO-incompatible living-donor lobar lung transplantationTsuyoshi Shoji
Department of Thoracic Surgery, Kyoto University, 54 Shogoin Kawahara cho, Kyoto, Japan
J Heart Lung Transplant 30:479-80. 2011..To our knowledge, this case represents the first successful living-donor lobar lung transplantation from ABO-incompatible donors...
Clinical applications of adoptive natural killer cell immunotherapy for cancer: current status and future prospectsHongfeng Guo
Department of Hematology, Wuxi People s Hospital, Nanjing Medical University, Wuxi, China
Onkologie 33:389-95. 2010..Future manipulation to improve NK cell adoptive immunotherapy by means of increasing target recognition and reducing inhibitory signaling is being explored...
Graft-versus-host diseaseS Choi
Blood and Marrow Transplantation Program, Department of Internal Medicine, Division of Hematology Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI 48109 0942, USA
Panminerva Med 52:111-24. 2010..In this article we review current and recent advances made in understanding of the cross-talk between these multiple cells and inflammatory molecules that have been implicated in the biology of GVHD...
A pilot study of fat allograft transplantation in immunocompetent rabbits for potential neurosurgical applicationsJohn S Kuo
Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, University of Toronto, Ontario, Canada
J Neurosurg 114:441-5. 2011..The authors investigated the feasibility of using fat allografts (chemically treated to reduce the host immune response) for neurosurgical applications...
Human embryonic stem cell-derived mesenchymal stromal cell transplantation in a rat hind limb injury modelJuha P Laurila
MediCity Research Laboratory, University of Turku, Turku, Finland
Cytotherapy 11:726-37. 2009..In the present work we studied the distribution of human MSC in a rat hind limb ischemic injury model immediately after transplantation and also analyzed the recipient tissue response to transplanted cells...
Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines: regulation by KIR/HLA-class I interactionEmanuela Marcenaro
Dipartimento di Medicina Sperimentale and Centro di Eccellenza per le Ricerche Biomediche, Universita degli Studi di Genova, Genova, Italy
Blood 114:4108-16. 2009....
Immunological behavior of enhanced green fluorescent protein (EGFP) as a minor histocompatibility antigen with a special reference to skin isograft and specific regulation of local graft-versus-host reaction (GvHR)Xuan Chao Pan
Department of Artificial Organ and Transplantation Surgery, Graduate School of Medicine and Faculty of Medicine, University of Tokyo, 7 3 1 Hongo, Bunkyou ku, Tokyo 113 8655, Japan
Immunol Lett 123:103-13. 2009....
Allogeneic memory T cell responseBenny J Chen
Division of Cellular Therapy BMT, Duke University Medical Center, Durham, North Carolina, USA
Biol Blood Marrow Transplant 14:20-2. 2008..A clinical trial has been planned. Successful translation of this approach in the clinic will improve the safety, enhance the effectiveness, and broaden the scope of allogeneic hematopoietic stem cell transplantation...
Minor H antigens: genes and peptidesE Simpson
MRC Clinical Sciences Centre, Department of Immunology, Imperial College School of Medicine, Hammersmith Hospital, London, UK
Eur J Immunogenet 28:505-13. 2001....
Use of natural killer cells as immunotherapy for leukaemiaBartosz Grzywacz
Division of Blood and Marrow Transplantation, University of Minnesota, MN, USA
Best Pract Res Clin Haematol 21:467-83. 2008..Future modifications to improve NK cell adoptive immunotherapy by means of increasing target recognition and reducing inhibitory signalling are being explored...
Adult thymus transplantation with allogeneic intra-bone marrow-bone marrow transplantation from same donor induces high thymopoiesis, mild graft-versus-host reaction and strong graft-versus-tumour effectsTakashi Miyake
First Department of Pathology, Kansai Medical University, Moriguchi, Osaka, Japan
Immunology 126:552-64. 2009..Allogeneic IBM-BMT + ATT thus can induce high thymopoiesis, preserving strong GVT effects without severe GVHR...
Acute graft versus host diseaseDavid A Jacobsohn
Robert H Lurie Comprehensive Cancer Center and Division of Hematology Oncology Transplant, Children s Memorial Hospital, Chicago, IL, USA
Orphanet J Rare Dis 2:35. 2007..Additional management issues are attention to wound infections in skin GVHD and fluid/nutrition management in gastrointestinal GVHD. About 50% of patients with acute GVHD will eventually have manifestations of chronic GVHD...
Functional characterization and gene expression analysis of CD4+ CD25+ regulatory T cells generated in mice treated with 2,3,7,8-tetrachlorodibenzo-p-dioxinNikki B Marshall
Department of Microbiology, Oregon State University, Corvallis, OR 97331, USA
J Immunol 181:2382-91. 2008..The generation of CD4(+) cells with regulatory function mediated through activation of the AhR by TCDD may represent a novel pathway for the induction of T-regs...
Limiting the amount and duration of antigen exposure during priming increases memory T cell requirement for costimulation during recallTamara L Floyd
Department of Surgery and Emory Transplant Center, Emory University, Atlanta, GA 30322, USA
J Immunol 186:2033-41. 2011..Thus, these data demonstrate the amount/duration of Ag exposure is a critical factor in determining Tmem's relative requirement for costimulation during the recall response after transplantation...
Absence of donor T-cell-derived soluble TNF decreases graft-versus-host disease without impairing graft-versus-tumor activityChiara Borsotti
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Blood 110:783-6. 2007..These data suggest that suppressing the secretion of solTNF by donor T cells significantly decreases GVHD without impairing GVT activity...
Relationship between graft-vs-host reactivity and possession of the high leukemia genotype hr-hrD L Gasser
J Immunol 111:1604-6. 1973
Mycophenolate mofetil in the management of alloimmune hemolytic anemia in ABO-compatible but non-identical pediatric liver transplantationRuben E Quiros-Tejeira
Department of Pediatrics, Texas Children s Hospital, Baylor College of Medicine, Houston, USA
J Pediatr Gastroenterol Nutr 41:125-8. 2005
Lichen planus-like eruption following autologous bone marrow transplantation for chronic myeloid leukaemiaJ A Pagliaro
Department of Dermatology, Princess Alexandra Hospital, Brisbane, Queensland, Australia
Australas J Dermatol 42:188-91. 2001..The eruption resolved with topical betamethasone valerate 0.1% cream despite the ongoing use of the immunomodulatory agent interferon-alpha2b. Such a reaction in an autologous setting has only been described once previously...
Peripheral regulation of graft-versus-host alloreactivity in mixed chimeric miniature swineS M Kunisaki
Transplantation Biology Research Center, Massachusetts General Hospital, MGH-East, Building 149-9019, 13th Street, Boston, MA 02129, USA
Transplantation 72:523-6. 2001....
A role for cytokine measurement in therapeutic monitoring of immunosuppressive drugs following lung transplantationP A Corris
Clin Exp Immunol 139:176-8. 2005
The Mortimer M. Bortin Lecture: to destroy by the reaction of immunity: the search for separation of graft-versus-leukemia and graft-versus-hostRobert L Truitt
Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA
Biol Blood Marrow Transplant 10:505-23. 2004....
Contribution of interleukin-1 to Th1- and Th2-dependent variants of chronic graft-versus-host reactionV A Kozlov
Research Institute of Clinical Immunology, Siberian Division of the Russian Academy of Medical Sciences, Novosibirsk
Bull Exp Biol Med 132:769-71. 2001..These variants of chronic graft-versus-host reaction are characterized by different changes in interleukin-1 level...
[Hemolytic anemia caused by graft-versus-host reaction in ABO-nonidentical renal transplants from blood group O donors]R Peces
Servicio de Nefrologia, Hospital Central de Asturias, Oviedo
Nefrologia 21:395-401. 2001..Follow-up of these patients is warranted for the early detection and optimal management may be achieved by reduction of immunosuppression and change to mycophenolate mofetil...
Minor histocompatibility antigens: allo target molecules for tumor-specific immunotherapyEls Goulmy
Department of Immunohaematology and Bloodtransfusion, Leiden University Medical Center, Leiden, The Netherlands
Cancer J 10:1-7. 2004....
Novel method for in vitro depletion of T cells by monoclonal antibody-targeted photosensitizationT Berki
Department of Immunology and Biotechnology, University Medical School of Pecs, Hungary
J Immunol Methods 211:139-46. 1998..This method can be useful for selective destruction of one population (target cell) in an in vitro heterogeneous cell mixture, e.g., in bone marrow transplants for T cell depletion to avoid graft vs. host reaction...
[Cancer cell therapy: what future?]Jacques Olivier Bay
Bull Cancer 90:675-6. 2003
Graft-versus-host-reactive donor CD4 cells can induce T cell-mediated rejection of the donor marrow in mixed allogeneic chimeras prepared with nonmyeloablative conditioningYong-Mi Kim
Transplantation Biology Research Center, Bone Marrow Transplantation Section, Massachusetts General Hospital/Harvard Medical School, MGH-East Bldg 149-5102, 13th St, Boston, MA 02129, USA
Blood 103:732-9. 2004..Thus, DLIs can paradoxically induce marrow rejection by residual host alphabeta T cells. These results have implications for the timing of and use of subset depletion of DLIs in recipients of nonmyeloablative transplants...
Complete remission of tumour with interleukin 2 therapy in a patient with non-Hodgkin's lymphoma post allogeneic bone marrow transplant associated with polyclonal T-cell bone marrow lymphocytosisThomas L Kiss
Bone Marrow Transplant Service, Department of Medical Oncology and Haematology, Princess Margaret Hospital/University Health Network, University of Toronto, Toronto, Canada
Br J Haematol 120:523-5. 2003..The patient remains in complete remission 37 months following allogeneic BMT...
Establishment of in vitro cellular model predicting histocompatibility in allograftY Hao
Department of Immunology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030
J Tongji Med Univ 21:277-9. 2001..It was suggested that the model could be used to predict correctly histocompatibility between donor and recipient...
Donor T cell and host NK depletion improve the therapeutic efficacy of allogeneic bone marrow cell reconstitution in the nonmyeloablatively conditioned tumor-bearing hostSusanne Hummel
Department of Tumor Progression and Tumor Defense, German Cancer Research Center, Heidelberg
J Leukoc Biol 72:898-912. 2002..Thus, concomitant depletion of host NK and donor T cells is advantageous when approaching therapeutic treatment of solid tumors by allogeneic reconstitution of the nonmyeloablatively conditioned host...
Immune reconstitution in pediatric stem-cell transplantationJ J Auletta
Division of Pediatric Hematology Oncology, Rainbow Babies and Children s Hospital, 11100 Euclid Avenue, Cleveland, OH 44106, USA
Front Biosci 6:G23-32. 2001..Future studies addressing these findings are needed to complement novel immunotherapies emerging from the field of transplant immunology...
[Proteasome inhibitors]J Alexandre
Service de Medecine Interne, Unité d Oncologie Médicale, Groupe Hospitalier Cochin Saint Vincent De Paul, 27, rue du Faubourg Saint Jacques, 75014 Paris, France
Rev Med Interne 26:812-5. 2005..Proteasome is involved in cell cycle and apoptosis regulation. Its deregulation could participate to oncogenesis...
Photochemical treatment with S-59 psoralen and ultraviolet A light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantationR L Truitt
Department of Pediatrics and Cancer Center, Medical College of Wisconsin, Milwaukee 53226, USA
J Immunol 163:5145-56. 1999..Thus, PCT ex vivo offers a simple, rapid, and inexpensive method by which to control the fate of naive and primed T cells in vivo...
Factors governing the activation of adoptively transferred donor T cells infused after allogeneic bone marrow transplantation in the mouseNadira Durakovic
Divisions of Hematologic Malignancies, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA
Blood 109:4564-74. 2007....
Research Grants
- ORTHOTOPIC LIVER TRANSPLANTATIONThomas Starzl; Fiscal Year: 2001..Moreover, the investigators will attempt to develop novel techniques to modify the number and character of the donor cells that ultimately reside in the recipient and promote tolerance to the allograft. ..
- MECHANISMS IN SUCCESSFUL THERAPY OF GVHD WITH MOABROBERT TRUITT; Fiscal Year: 2001..Mechanistic insights gained from the studies, together with the biological principles identified, will facilitate the translational application of MoAb to clinical BMT. ..
- MANIPULATION OF GVL/GVH REACTIONS IN ALLOGENEIC BMTROBERT TRUITT; Fiscal Year: 1993..The proposed studies will help identify strategies and reagents that merit further evaluation in clinical BMT as well as those that require modification before use...
- CD200 Expression on Apoptotic DCs and Immune ToleranceROBERT TRUITT; Fiscal Year: 2005..These studies will also provide new insight into a novel molecular pathway that is a target for enhancement of antitumor immunity and for prevention of graft rejection. ..
- Allospecific Immunoregulatory T Cells in BMT RecipientsROBERT TRUITT; Fiscal Year: 2003....
- CLONAL GVL/GVH REACTIONS AND ADOPTIVE IMMUNOTHERAPYROBERT TRUITT; Fiscal Year: 1990..The proposed studies are a systematic approach to optimizing the GVL effect while minimizing the GVH effect of cloned CTL. In addition, they will enable us to gain significant new insights into the pathogenesis of clonal GVH reactions...
- HEMATOPOIETIC GROWTH FACTORS IN A CANINE STEM CELL MODELRichard Nash; Fiscal Year: 2003....
- Strategies for prenatal stem cell transplantationAlan W Flake; Fiscal Year: 2010..The ultimate goal of these studies is to develop safe and effective strategies that can be translated to the in utero treatment of a broad range of human genetic hematologic disorders including Sickle Cell Disease and Thalassemia. ..
- MODULATING GVH/GVL POST-BMT USING TK EXPRESSING T CELLSWilliam Drobyski; Fiscal Year: 2004..The overall goal of this project is to selectively modulate T-cell function and survival in vivo in order to augment the therapeutic index of allogeneic BMT. ..
- Nonmyeloablative Hematopoietic Cell Transplantation for Severe Systemic SclerosisRichard Nash; Fiscal Year: 2006..The unique observations in this study regarding responses and recovery of organs after inducing a sustained remission of SSc will serve to focus and direct other non-transplant research activities. ..
- Fetal Stromal Progenitor CellsAlan Flake; Fiscal Year: 2006..abstract_text> ..
- Graft Versus Host Disease and AutoimmunityWilliam Drobyski; Fiscal Year: 2007....
- Augmentation of GVL Reactivity Without GVHDWilliam Drobyski; Fiscal Year: 2007..Better understanding of how to reduce this complication while at the same time preserving the beneficial effects that result from the transplant will lead to new therapies and better outcomes for patients. ..
- Graft Versus Host Disease and AutoimmunityWilliam Drobyski; Fiscal Year: 2009....
- Fetal Biology and Therapy Training ProgramAlan Flake; Fiscal Year: 2007..Penn Graduate School and IHGT. This request is made for 2 Trainee slots in year 1, 3 Trainee slots in year 2, and 4 Trainee slots each year thereafter. ..
- Lung Transplantation and Immune Tolerance in Young RecipientsRichard Nash; Fiscal Year: 2007..Development of preclinical strategies for the induction of lung-specific tolerance in large animal models to prevent acute and chronic rejection will increase the probability of successful translation to human studies. ..
- Protection from GVHD with Gene-Modified Donor T CellsRichard Nash; Fiscal Year: 2007....
- ENGRAFTING SENSITIZED HOSTS WITH NONABLATIVE REGIMENSRichard Nash; Fiscal Year: 2002..By lessening the morbidity and mortality associated with conventional conditioning, these studies could significantly change the management of selected inherited red blood cell diseases. ..
- PRENATAL STRATEGIES FOR TREATMENT OF HEMOGLOBINOPATHIESAlan Flake; Fiscal Year: 2002..abstract_text> ..
- GENE MODIFIED CLONED PIGSThomas Starzl; Fiscal Year: 2003..abstract_text> ..
- Regulation of Engraftment & Immunity by GD T CellsWilliam Drobyski; Fiscal Year: 2005....
- Strategies for Prenatal Stem Cell TranplantationAlan Flake; Fiscal Year: 2004..The studies in this proposal are designed to identify and test strategies to increase engraftment after IUHSCTx. This would allow application of this approach to a broad range of prenatally diagnosed genetic disorders. ..
- Augmentation of GVL Reactivity Without GVHDWilliam Drobyski; Fiscal Year: 2009..Better understanding of how to reduce this complication while at the same time preserving the beneficial effects that result from the transplant will lead to new therapies and better outcomes for patients. ..
- Strategies for prenatal stem cell transplantationAlan Flake; Fiscal Year: 2007..The ultimate goal of these studies is to develop safe and effective strategies that can be translated to the in utero treatment of a broad range of human genetic hematologic disorders including Sickle Cell Disease and Thalassemia. ..
- Translational Research in Multiple MyelomaCAROL HUFF; Fiscal Year: 2006..abstract_text> ..
